SIBN SI-BONE, Inc.
SI-BONE, Inc. (SIBN) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.13 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.9% since its last earnings release on August 3, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About SI-BONE, Inc.
SI-BONE is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 4 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.